Outsourcing market’s recently IPO'd stock prices see early spike
Between May 2013, when Quintiles went public, and this week, newly public companies’ stocks in the biopharma outsourcing space have all seen their prices rise by more than 35%.
Archives for February 26, 2015
Academics urge updating WHO, ICH guidelines to ensure quality drugs used in clinical trials
The use of substandard and falsified drugs in clinical trials has been neglected and new information on product quality should be included in the GCP (good clinical practice) guidelines from the WHO and ICH, academics contend in the British Medical Journal.
Icon posts solid quarterly results, sees stock rise 10%
Dublin-based CRO Icon saw its quarterly net revenue, backlog and income rise over the same quarter last year, all of which helped to boost its stock by about 10% on Wednesday.
Bayer manufactures for biologics start-up in CoLaborator project
Bayer has announced a strategic alliance to manufacture a preclinical candidate for small biotech Aronora.
Salix latest purchase by Valeant after Dendreon deal
Valeant has signed a $14.5bn deal to acquire GI drugmaker Salix days after agreeing to purchase Provenge-maker Dendreon.
Japanese companies acquire CMO KBI Biopharma
Tokyo-based CMIC Holdings Co., Innovation Network Corporation of Japan (INCJ), and JSR have agreed to acquire KBI Biopharma, a contract development and manufacturing organization with facilities in Durham and Research Triangle Park, North Carolina and...
California bill would require Big Pharma to unveil how drugs are priced
A new California bill introduced earlier this week would, for the first time, require pharma companies to unveil a number of unique operational costs as a way to better understand drug pricing.